Tapinarof/Symbiox (Benvitimod Cream) – Plaque Psoriasis
- Generic Name/Brand Name: Benvitimod / Symbiox Benvitimod Cream
- Indications: Plaque Psoriasis in adults, Atopic Dermatitis and Palmoplantar Pustulosis.
- Dosage Form: Topical cream
- Specification: 10g : 0.1 g
Benvitimod Cream (Tapinarof) Application Scope
Used for the treatment of mild-to-moderate plaque psoriasis by modulating immune response and reducing skin inflammation.
Emerging studies support use in other inflammatory skin diseases.

Benvitimod Cream Characteristics
-
Ingredients:
Benvitimod (Tapinarof) 1%Properties:
Non-steroidal, small-molecule AhR (aryl hydrocarbon receptor) modulator with anti-inflammatory and antioxidant effects.Packaging Specification:
Usually supplied in 10g or 30g aluminum tubes (varies by market)Storage:
Store below 25°C, protect from light and moisture.Expiry Date:
Refer to packagingExecutive Standard:
[To be filled based on registration—e.g., Chinese Pharmacopoeia or FDA standards]Approval Number:
H20193146 (China, 2019)Date of Revision:
[Insert date]Manufacturer:
Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd.
Guidelines for the Use of Benvitimod Cream
-
Dosage and Administration: Apply a thin layer of 1% cream to affected areas once daily.
-
Administration: Topical use only. Do not apply to broken skin, eyes, or mucous membranes.
-
Missed Dose: Apply as soon as remembered. Skip if it’s almost time for the next dose.
-
Adverse Reactions:
Common Adverse Reactions (≥5% and >3% higher than placebo):
-
Folliculitis
-
Contact dermatitis
-
Pruritus
-
Headache
Serious Adverse Reactions:
-
Hypersensitivity reactions (rare)
-
Severe skin irritation in sensitive individuals
-
-
Contraindications:
Patients with known hypersensitivity to benvitimod or any excipients.
-
Precautions:
- Skin Reactions: Discontinue if irritation or allergic reaction occurs.
- Pregnancy and Lactation: Use only if clearly needed; consult physician.
- Avoid Occlusive Dressings: Unless directed by physician.
Benvitimod Cream Interactions
-
No major systemic drug interactions reported due to minimal systemic absorption. Avoid concurrent use with other topical agents on the same area unless prescribed.
Note:
- If there is a new packaging for the drug, the new packaging shall prevail. The above information is sourced from DengYue Medicine.
- This content is for reference only. Prescription drugs must be used under a doctor’s guidance and purchased from authorized sources.










Reviews
There are no reviews yet.